Daily Archives: March 18, 2016

Clarity awarded $1 million Accelerating Commercialisation Grant

Sydney, Australia 18 March 2016 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, has been awarded the maximum amount of Accelerating Commercialisation grant funding. This grant is part of the Australian Government’s Entrepreneurs’ Programme and will be used to commercialise Clarity’s novel radiopharmaceutical for treating cancer, SARTATE™. The grant, valued…

Clarity is awarded Research Connections Grant

Sydney, Australia 18 December 2015 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, has been awarded a Research Connections Grant under the Entrepreneurs’ Programme. The grant, valued at $50,000, will go toward funding the employment of Australian scientist Charmaine Jeffery as Preclinical Development Manager, who will be responsible for conducting…